We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
17/8/2022 12:16 | Final tranche bought today. Fully invested back to my amount pre split. | berny3 | |
17/8/2022 11:34 | GSK xdiv tomorrow, 16.25p per share | tradermichael | |
17/8/2022 11:31 | Gsk are the originators of this drug. Spells big trouble. Osteoporosis also linked to this drug as it blocks calcium absorption. 10 years plus fighting this in US courts, dire, still a load of debt too and shyte management. Poor suckers who bought haleon too. Buy US, UK shares like the brexit basket case U.K. itself, totally fxcked. | porsche1945 | |
17/8/2022 11:12 | Does my memory serve me correctly that this goes ex divi tomorrow? | knowing | |
17/8/2022 10:28 | Guess many missed this “ Analysts at Deutsche Bank said some "billions of dollar magnitude" liabilities could be incurred ” there are many yes many Cancer Claims put forward. My question is WHY did the latest claimant bail out? Is he too ill to proceed. Its a sad day for those who have Cancer. Will we ever know the Truth?? GSK is now a gamblers choice so Do You Feel Lucky?? | halfpenny | |
17/8/2022 09:32 | More halfwit than halfpenny. Pathetic trolling | alibizzle | |
17/8/2022 09:22 | Tomorrow is ex dividend for Q2 22https://www.gsk.co | maxplus2 | |
17/8/2022 08:58 | So no then. | spoole5 | |
17/8/2022 08:52 | Driven by Graph the next support level is £12.50 which has a high chance of breaking as more Cancer Claims are made. So do you feel lucky?? I will buy at a much lower level. | halfpenny | |
17/8/2022 08:42 | Do you have a short position? | spoole5 | |
17/8/2022 08:37 | I did say once 1400 breaks then its ALL OVER….is this the day GSK collapses. GSK are NOW AN EXTREMELY HIGH RISKIts only greed that keeps many holding onto GSK. Its therefore important that many are aware of the Risks and avoid the hype its a good investment at this time of many Cancer Claims. So dont fall into any traps as MM’s will sell before you do. Q. Do you feel lucky??? | halfpenny | |
17/8/2022 08:35 | OK - I cant look any more - its crashing like a stone. I'll be back some time next week when the dust settles. Blimey. | netcurtains | |
17/8/2022 08:28 | Have to feel sorry for plaintiffs...There was no case against GSK and Sanofi as the guy said he only took generics for heartburn hence the payout by the generics firms. | bobo18 | |
17/8/2022 08:05 | One last shake out maybe? We can but hope!! | tuftymatt | |
17/8/2022 08:05 | Blimey - was not expecting that. | netcurtains | |
17/8/2022 08:04 | And spare a thought also for Joseph Bayer - it is easy to forget that whatever the merits of the situation are for GSK, it is a story about many people going through misery. Good luck to Joseph. | spyder | |
17/8/2022 08:00 | This is confusing news I agree, but I’m not sure the RNS gives the full story. See this from Bloomberg - ‘Generic drugmakers Teva Pharmaceutical Industries Ltd., Perrigo Co., Sun Pharmaceutical Industries Inc. and Dr. Reddy’s Laboratories Inc. agreed to a combined settlement of more than $500,000 with Joseph Bayer after he alleged the popular heartburn medication caused his esophageal cancer, according to the people. The settlements occurred over the course of months, but the plaintiff’s lawyers on Monday notified the judge overseeing the case that they are dropping the lawsuit after Bayer returned to the hospital for cancer treatment.’ I don’t think this is the silver bullet that GSK needs but lets hope the market likes it anyway, but perhaps be cautious? | spyder | |
17/8/2022 07:49 | this is Tempus from The Times on 20 July when the share price was £17.76. BUY! | unastubbs | |
17/8/2022 07:41 | though actually i can't see if the statement came out after nyse close...so yeah, looking forward to open (still on the fence btw) | unastubbs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions